Predicting the development of normal tension glaucoma and related risk factors in normal tension glaucoma suspects.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
17 08 2021
17 08 2021
Historique:
received:
19
02
2021
accepted:
08
07
2021
entrez:
18
8
2021
pubmed:
19
8
2021
medline:
11
11
2021
Statut:
epublish
Résumé
This study investigated the predicted risk factors for the development of normal-tension glaucoma (NTG) in NTG suspects. A total of 684 eyes of 379 NTG suspects who were followed-up for at least 5 years were included in the study. NTG suspects were those having (1) intraocular pressure within normal range, (2) suspicious optic disc (neuroretinal rim thinning) or enlarged cup-to-disc ratio (≥ 0.6), but without definite localized retinal nerve fiber layer (RNFL) defects on red-free disc/fundus photographs, and (3) normal visual field (VF). Demographic, systemic, and ocular characteristics were determined at the time of the first visit via detailed history-taking and examination of past medical records. Various ocular parameters were assess using spectral-domain optical coherence tomography and Heidelberg retinal tomography. Conversion to NTG was defined either by the presence of a new localized RNFL defect at the superotemporal or inferotemporal region on disc/fundus red-free photographs, or presence of a glaucomatous VF defect on pattern standard deviation plots on two consecutive tests. Hazard ratios were calculated with the Cox proportional hazard model. In total, 86 (12.6%) of the 684 NTG suspects converted to NTG during the follow-up period of 69.39 ± 7.77 months. Significant (P < 0.05, Cox regression) risk factors included medication for systemic hypertension, longer axial length, worse baseline VF parameters, thinner baseline peripapillary RNFL, greater disc torsion, and lamina cribrosa (LC) thickness < 180.5 μm (using a cut-off value obtained by regression analysis). Significant (P < 0.05, Cox regression) risk factors in the non-myopic NTG suspects included medication for systemic hypertension and a LC thinner than the cut-off value. Significant (P < 0.05, Cox regression) risk factors in the myopic NTG suspects included greater disc torsion. The results indicated that 12.6% of NTG suspects converted to NTG during the 5-6-year follow-up period. NTG suspects taking medication for systemic hypertension, disc torsion of the optic disc in the inferotemporal direction, and thinner LC of the optic nerve head at baseline were at greater risk of NTG conversion. Related baseline risk factors were different between myopic and non-myopic NTG suspects.
Identifiants
pubmed: 34404847
doi: 10.1038/s41598-021-95984-7
pii: 10.1038/s41598-021-95984-7
pmc: PMC8371169
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16697Informations de copyright
© 2021. The Author(s).
Références
Am J Ophthalmol. 2013 May;155(5):843-51
pubmed: 23394905
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5355-5365
pubmed: 30398627
Invest Ophthalmol Vis Sci. 2014 Mar 10;55(3):1419-26
pubmed: 24508789
Sci Rep. 2017 Jun 14;7(1):3489
pubmed: 28615670
Invest Ophthalmol Vis Sci. 2013 Oct 09;54(10):6570-7
pubmed: 24022009
Invest Ophthalmol Vis Sci. 2014 Jul 01;55(8):4991-8
pubmed: 24985480
Ophthalmology. 2014 May;121(5):1013-9
pubmed: 24507857
Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30
pubmed: 12049574
Curr Eye Res. 2016 Jun;41(6):806-13
pubmed: 26268599
J Glaucoma. 2006 Jun;15(3):223-8
pubmed: 16778645
PLoS One. 2016 Apr 21;11(4):e0153707
pubmed: 27100404
Am J Ophthalmol. 2014 Mar;157(3):550-7
pubmed: 24239773
Acta Ophthalmol. 2014 May;92(3):e185-93
pubmed: 24456145
Am J Ophthalmol. 2005 Feb;139(2):247-52
pubmed: 15733984
Invest Ophthalmol Vis Sci. 2014 Nov 25;56(1):156-63
pubmed: 25425302
Am J Hypertens. 2015 Sep;28(9):1077-82
pubmed: 25767134
Am J Ophthalmol. 2002 May;133(5):679-85
pubmed: 11992866
Eye (Lond). 2017 Apr;31(4):578-587
pubmed: 27935604
Am J Ophthalmol. 2016 Mar;163:29-37
pubmed: 26627918
Int Ophthalmol. 1991 Jan;15(1):1-7
pubmed: 1707038
Acta Ophthalmol. 2015 Mar;93(2):e94-9
pubmed: 24975750
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3759-3769
pubmed: 28738420
Sci Rep. 2018 Jan 15;8(1):738
pubmed: 29335420
Br J Ophthalmol. 2021 Mar;105(3):367-373
pubmed: 32434775
Eye (Lond). 2010 May;24(5):857-63
pubmed: 19680281
Curr Eye Res. 2019 Sep;44(9):968-974
pubmed: 30963796
Arch Ophthalmol. 2009 Jul;127(7):894-9
pubmed: 19597111
Br J Ophthalmol. 2019 Mar;103(3):374-378
pubmed: 29793928
J Glaucoma. 2016 Jun;25(6):e591-5
pubmed: 25943739
Invest Ophthalmol Vis Sci. 2014 Jan 09;55(1):233-9
pubmed: 24204049
Curr Eye Res. 2019 Sep;44(9):1026-1033
pubmed: 31117833
Ophthalmology. 2012 Sep;119(9):1844-51
pubmed: 22595297
Ophthalmology. 2012 Jan;119(1):10-20
pubmed: 22015382
JAMA Ophthalmol. 2019 Apr 1;137(4):425-433
pubmed: 30730530
Arch Ophthalmol. 2010 Mar;128(3):276-87
pubmed: 20212196
Ophthalmology. 2011 Oct;118(10):2050-7
pubmed: 21820741
Ophthalmology. 2019 Sep;126(9):1315-1323
pubmed: 30953743
Sci Rep. 2017 Mar 06;7:43734
pubmed: 28262703
Sci Rep. 2019 Apr 29;9(1):6612
pubmed: 31036869
Ophthalmology. 2015 Apr;122(4):721-9
pubmed: 25433610
Am J Ophthalmol. 2015 Mar;159(3):512-8.e1
pubmed: 25498357
Ophthalmology. 2013 Apr;120(4):745-52
pubmed: 23260259
Eur J Ophthalmol. 1996 Jul-Sep;6(3):273-8
pubmed: 8908433
Graefes Arch Clin Exp Ophthalmol. 1994 Jun;232(6):361-7
pubmed: 8082844
JAMA Ophthalmol. 2014 Sep;132(9):1068-75
pubmed: 24921983
Sci Rep. 2017 Dec 21;7(1):18001
pubmed: 29269862
Br J Ophthalmol. 2017 Dec;101(12):1649-1653
pubmed: 28416494
Medicine (Baltimore). 2017 Apr;96(14):e6295
pubmed: 28383403
Ophthalmology. 2013 Sep;120(9):1798-803
pubmed: 23622874
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1293-300
pubmed: 26998715
Am J Ophthalmol. 2015 Jan;159(1):160-8.e1-2
pubmed: 25448320
PLoS One. 2019 Mar 15;14(3):e0213714
pubmed: 30875403
Acta Cardiol. 2020 Feb;75(1):54-58
pubmed: 30650042
Ophthalmology. 2018 Dec;125(12):1898-1906
pubmed: 29945800
Br J Ophthalmol. 2015 Jan;99(1):69-74
pubmed: 25091955